Anxiety Disorder Treatment Market: A Deep Dive into the Pharmacological Landscape and Drug Pipeline Innovations
The Historical Dominance and Limitations of Conventional Anxiolytics The pharmacological segment has historically dominated the anxiety treatment landscape, primarily relying on established classes such as Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin-Norepinephrine Reuptake Inhibitors (SNRIs), and benzodiazepines. While effective for many patients, these drugs often come with...
0 Comments 0 Shares 438 Views 0 Reviews